News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wahl Bryan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2023 |
4
| Wahl Bryan (General Counsel) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 350 shares
@ $12.89, valued at
$4.5k
Sold 357 shares
@ $12.64, valued at
$4.5k
Sold 371 shares
@ $12.15, valued at
$4.5k
|
|
| 03/21/2023 |
4
| Wahl Bryan (General Counsel) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 339 shares
@ $13.28, valued at
$4.5k
Sold 357 shares
@ $12.61, valued at
$4.5k
|
|
| 03/17/2023 |
4
| Wahl Bryan (General Counsel) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 337 shares
@ $13.43, valued at
$4.5k
Exercised 4,790 restricted stock units
@ $0 |
|
| 03/10/2023 |
4
| Wahl Bryan (General Counsel) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Granted 42,802 options to buy
@ $15, valued at
$642k
Granted 28,993 restricted stock units
@ $0 |
|
| 12/06/2022 |
4
| Wahl Bryan (General Counsel) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 1,154 shares
@ $16.9, valued at
$19.5k
|
|
| 12/01/2022 |
4
| Wahl Bryan (General Counsel) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 1,183 shares
@ $16.5, valued at
$19.5k
Sold 1,164 shares
@ $16.75, valued at
$19.5k
Exercised 10,251 restricted stock units
@ $0 |
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|